Axsome Therapeutics Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Axsome Therapeutics Stock Summary

Axsome Therapeutics competes with Incyte, Sarepta Therapeutics, ACADIA Pharmaceuticals, Viking Therapeutics, and Madrigal Pharmaceuticals. Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system disorders in the United States. The company was incorporated in 2012 and is based in New York, New York. Axsome Thera operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 198 people.

Axsome Therapeutics Key Financial Ratios

Axsome Therapeutics Key Balance Sheet Accounts

Axsome Therapeutics Key Income Statement Accounts

Axsome Therapeutics Key Cash Accounts

Axsome Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Axsome Therapeutics's current stock value. Our valuation model uses many indicators to compare Axsome Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Axsome Therapeutics competition to find correlations between indicators driving Axsome Therapeutics's intrinsic value. More Info.Axsome Therapeutics is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Axsome Therapeutics' Return On Equity is very stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Axsome Therapeutics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Axsome Therapeutics Systematic Risk

Today, most investors in Axsome Therapeutics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Axsome Therapeutics' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Axsome Therapeutics growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Axsome Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Axsome Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Axsome Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Axsome Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Axsome Therapeutics's daily price indicators and compare them against related drivers.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Axsome Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. To learn how to invest in Axsome Stock, please use our How to Invest in Axsome Therapeutics guide.You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Axsome Therapeutics. If investors know Axsome will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Axsome Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Axsome Therapeutics is measured differently than its book value, which is the value of Axsome that is recorded on the company's balance sheet. Investors also form their own opinion of Axsome Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Axsome Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Axsome Therapeutics' market value can be influenced by many factors that don't directly affect Axsome Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Axsome Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Axsome Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Axsome Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.